Effectiveness of first‐line cetuximab in wild‐type RAS metastatic colorectal cancer according to tumour BRAF mutation status from the EREBUS cohort
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.14472
Abstract: Poor efficacy has been reported for patients with BRAF mutations for metastatic colorectal cancer (mCRC). read more here.
Keywords: metastatic colorectal; first line; colorectal cancer; effectiveness first ... See more keywords